Literature DB >> 26991965

Early severe scoliosis in a patient with atypical progressive pseudorheumatoid dysplasia (PPD): Identification of two WISP3 mutations, one previously unreported.

Lucia Sentchordi Montané1,2,3, Oliver R Marín4, Carlos I Rivera-Pedroza2,3, Elena Vallespín3,5, Ángela Del Pozo3,5, Karen E Heath2,3,5.   

Abstract

Progressive pseudorheumatoid dysplasia (PPD) is a rare autosomal recessive disorder characterized by spondyloepiphyseal dysplasia associated with pain and stiffness of multiple joints, enlargement of the interphalangeal joints, normal inflammatory parameters, and absence of extra-skeletal manifestations. Homozygous or compound heterozygous WISP3 mutations cause PPD. We report two siblings from a non-consanguineous Ecuadorian family with a late-onset spondyloepiphyseal dysplasia. Mutation screening was undertaken in the two affected siblings using a customized skeletal dysplasia next generation sequencing (NGS) panel and confirmed by Sanger sequencing. Two compound heterozygous mutations were identified in WISP3 exon 2, c.[190G>A];[197G>A] (p.[(Gly64Arg)];[(Ser66Asn)]) in the two siblings, both of which had been inherited. The p. (Gly64Arg) mutation has not been previously described whilst the p. (Ser66Asn) mutation has been reported in two PPD families. The two siblings presented with atypical PPD, as they presented during late childhood, yet the severity was different between them. The progression was particularly aggressive in the male sibling who suffered severe scoliosis by the age of 13 years. This case reaffirms the clinical heterogeneity of this disorder and the clinical utility of NGS to genetically diagnose skeletal dysplasias, enabling adequate management, monitorization, and genetic counseling.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  NGS; PPD; WISP3; progressive pseudorheumatoid dysplasia; scoliosis; skeletal dysplasias

Mesh:

Substances:

Year:  2016        PMID: 26991965     DOI: 10.1002/ajmg.a.37619

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

Review 1.  Progressive pseudorheumatoid dysplasia: a rare childhood disease.

Authors:  Sofia Torreggiani; Marta Torcoletti; Belinda Campos-Xavier; Francesco Baldo; Carlo Agostoni; Andrea Superti-Furga; Giovanni Filocamo
Journal:  Rheumatol Int       Date:  2018-10-16       Impact factor: 2.631

2.  Progressive pseudorheumotoid dysplasia: A presentation of four cases with slow and rapid progression and effects of early rehabilitation program.

Authors:  Esra Giray; İlker Yağcı; Huriye Nursel Elçioğlu
Journal:  Turk J Phys Med Rehabil       Date:  2019-01-29

3.  Pain evaluation in a sample of Turkish children with cerebral palsy and its association with dependency level, verbal abilities, and the quality of life of patients and sociodemographic status, depression, and quality of life of their caregivers.

Authors:  Esra Giray; Halil İbrahim Şimşek; Mustafa Aydoğduoğlu; Alp Çağatay Kangal; Abdülkadir Çelik; Cihat Kurt; Evrim Karadağ Saygı
Journal:  Turk J Phys Med Rehabil       Date:  2018-02-23

4.  WISP3 mutation associated with pseudorheumatoid dysplasia.

Authors:  M Reza Sailani; James Chappell; Inlora Jingga; Anil Narasimha; Amin Zia; Janet Linnea Lynch; Safoura Mazrouei; Jonathan A Bernstein; Omid Aryani; Michael P Snyder
Journal:  Cold Spring Harb Mol Case Stud       Date:  2018-02-01

5.  CCN6 mutation detection in Chinese patients with progressive pseudo-rheumatoid dysplasia and identification of four novel mutations.

Authors:  Yingjie Wang; Ke Xiao; Yuemei Yang; Zhihong Wu; Jin Jin; Guixing Qiu; Xisheng Weng; Xiuli Zhao
Journal:  Mol Genet Genomic Med       Date:  2020-04-29       Impact factor: 2.183

6.  Delayed-onset of progressive pseudorheumatoid dysplasia in a Chinese adult with a novel compound WISP3 mutation: a case report.

Authors:  Qiongyi Hu; Jing Liu; Yi Wang; Jiucun Wang; Hui Shi; Yue Sun; Xinyao Wu; Chengde Yang; Jialin Teng
Journal:  BMC Med Genet       Date:  2017-12-15       Impact factor: 2.103

7.  Progressive pseudorheumatoid dysplasia with new-found gene mutation of Wntl inducible signaling pathway protein 3.

Authors:  Wenji Chen; Shiyan Mo; Gui Luo; Yanyan Wang; Xiaohu Deng; Jian Zhu; Wei Zhao
Journal:  Pediatr Rheumatol Online J       Date:  2018-09-10       Impact factor: 3.054

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.